| Cited in | International search | Type: | Non-patent literature | Publication information: | [XI] ALTEN RIEKE; GRAM HERMANN; JOOSTEN LEO A; BERG WIM B VAN DEN; SIEPER JOACHIM; WASSENBERG SIEGFRID; BURMESTER GERD; VAN RIEL PIET;: "The human anti-IL-1 monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis", ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, vol. 10, no. 3, 5 June 2008 (2008-06-05), pages 1 - 9, XP021041234, ISSN: 1478-6354 [X] 1-3,7-13,15,17,19-55,67-70 * page 4, column r - page 5; tables 2,3 * * page 3, column l, paragraph 1; figures 1,3 * * page 6, column r *[I] 4-6,14,16,18,56-66,71 | Type: | Non-patent literature | Publication information: | [I] GEIGER T; TOWBIN H; COSENTI-VARGAS A; ZINGEL O; ARNOLD J; RORDORF C; GLATT M; VOSBECK K: "NEUTRALIZATION OF INTERLEUKIN-1 BETA ACTIVITY IN VIVO WITH A MONOCLONAL ANTIBODY ALLEVIATES COLLAGEN-INDUCED ARTHRITIS IN DBA/1 MICE AND PREVENTS THE ASSOCIATED ACUTE-PHASE RESPONSE", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, PACINI, PISA, IT, vol. 11, no. 5, 1 September 1993 (1993-09-01), pages 515 - 522, XP009081237, ISSN: 0392-856X [I] 1-71 * page 516, column l, paragraph 4 - paragraph 5 * * page 516, column r, paragraph 2 - paragraph 4 * * page 517, column r, paragraph l - page 519, column r, paragraph 2; figures 3-4 * | Type: | Non-patent literature | Publication information: | [IP] OWYANG A M; ESPOSITO L; VANEGAS S; GROSS L; MASAT L; CORBIN J; ROELL M; HORWITZ A; HAAK-FRENDSCHO M; KANTAK S: "Efficacy of XOMA 052 anti-IL-1.beta. antibody in the DBA/1 mouse collagen-induced arthritis model", ARTHRITIS AND RHEUMATISM, LIPPINCOTT, PHILADELPHIA, US, vol. 58, no. 9 Suppl. S, 1 September 2008 (2008-09-01), pages S265, XP008111143, ISSN: 0004-3591 [IP] 1-71 * abstract * | Type: | Non-patent literature | Publication information: | [A] BOISSIER M G; BERIN-MAGHIT S; CAPINI C; CHOMILLIER J; MULLER S; THERWATH A; ZAGURY J; BESSIS N: "PROTECTION OF COLLAGEN-INDUCED ARTHRITIS WITH ACTIVE IMMUNIZATION AGAINST PEPTIDES OF INTERLEUKIN-1 (IL-1) BETA INDUCING SELF ANTI-IL-1 BETA ANTIBODIES", ANNALS OF THE RHEUMATIC DISEASES, BRITISH MEDICAL ASSOCIATION, LONDON, vol. 64, no. SUP. 3, 8 June 2005 (2005-06-08), XP008077941, ISSN: 0003-4967 [A] 1-71 * abstract * | Type: | Non-patent literature | Publication information: | [IP] MEYER KATHLEEN; DER KENNETH; MA JEREMY; ESPINOZA YERO; CAO LICHING; GASPER CAROLYN; BAUER ROBERT; BECHTEL CHARLES; TICHENOR STEVEN: "Nonclinical Safety Evaluation of XOMA 052, a Monoclonal Antibody Targeting IL-1 beta, in 4-and 13-Week Repeat-Dose Toxicity Studies in Cynomolgus Monkeys", INTERNATIONAL JOURNAL OF TOXICOLOGY, vol. 28, no. 1, January 2009 (2009-01-01), & 29TH ANNUAL MEETING OF THE AMERICAN-COLLEGE-OF-TOXICOLOGY; TUCSON, AZ, USA; NOVEMBER 09 -12, 2008, pages 60 - 61, XP008111116 [IP] 1-71 * abstract * | Cited in | Examination | Type: | Non-patent literature | Publication information: | ALETAHA DANIEL ET AL: "2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.", ARTHRITIS AND RHEUMATISM SEP 2010 LNKD- PUBMED:20872595, vol. 62, no. 9, September 2010 (2010-09-01), pages 2569 - 2581, ISSN: 1529-0131 |
